全文获取类型
收费全文 | 4082篇 |
免费 | 276篇 |
国内免费 | 98篇 |
专业分类
耳鼻咽喉 | 64篇 |
儿科学 | 1篇 |
妇产科学 | 9篇 |
基础医学 | 429篇 |
口腔科学 | 298篇 |
临床医学 | 833篇 |
内科学 | 82篇 |
皮肤病学 | 64篇 |
神经病学 | 1081篇 |
特种医学 | 132篇 |
外科学 | 313篇 |
综合类 | 541篇 |
现状与发展 | 1篇 |
预防医学 | 57篇 |
眼科学 | 36篇 |
药学 | 242篇 |
中国医学 | 243篇 |
肿瘤学 | 30篇 |
出版年
2024年 | 5篇 |
2023年 | 48篇 |
2022年 | 69篇 |
2021年 | 144篇 |
2020年 | 126篇 |
2019年 | 102篇 |
2018年 | 99篇 |
2017年 | 118篇 |
2016年 | 141篇 |
2015年 | 103篇 |
2014年 | 272篇 |
2013年 | 244篇 |
2012年 | 250篇 |
2011年 | 264篇 |
2010年 | 230篇 |
2009年 | 236篇 |
2008年 | 207篇 |
2007年 | 186篇 |
2006年 | 174篇 |
2005年 | 147篇 |
2004年 | 114篇 |
2003年 | 110篇 |
2002年 | 102篇 |
2001年 | 89篇 |
2000年 | 69篇 |
1999年 | 61篇 |
1998年 | 68篇 |
1997年 | 55篇 |
1996年 | 35篇 |
1995年 | 53篇 |
1994年 | 38篇 |
1993年 | 42篇 |
1992年 | 38篇 |
1991年 | 35篇 |
1990年 | 24篇 |
1989年 | 38篇 |
1988年 | 20篇 |
1987年 | 23篇 |
1986年 | 48篇 |
1985年 | 58篇 |
1984年 | 44篇 |
1983年 | 34篇 |
1982年 | 37篇 |
1981年 | 19篇 |
1980年 | 13篇 |
1979年 | 9篇 |
1978年 | 4篇 |
1976年 | 4篇 |
1974年 | 2篇 |
1972年 | 2篇 |
排序方式: 共有4456条查询结果,搜索用时 17 毫秒
1.
目的探讨短时程脊髓电刺激(temporary spinal cord stimulation, tSCS)治疗爆发痛合并触诱发痛的急性期带状疱疹的临床疗效。方法回顾性地分析同济大学附属第十人民医院疼痛科2020年1月—2020年12月收治的52例接受tSCS治疗的爆发痛合并触诱发痛的急性期带状疱疹患者的临床资料,评估在治疗前、治疗后3d、7d、14d、3个月、6个月的总体疼痛情况(numerical rating scale, NRS)评分、(simple McGill scores, McGill)评分、爆发痛情况(发生率、NRS评分、次数以及持续时间)、触诱发痛情况(发生率、分级)、术后不良反应等;评估在治疗前、治疗后7d、3个月、6个月的睡眠时长、睡眠中醒来次数、疼痛障碍指数(pain disorder index, PDI)、功能状态评分(Karnofsky score, KPS)、抑郁症筛查量表(patient health questionnaire depression module scale, PHQ-9)和焦虑症筛查量表(generalized anxiety disorder-7 scale, GAD-7)等。结果与治疗前相比,治疗后3d、7d、14d、3个月、6个月的总体疼痛NRS评分、总体疼痛MCGILL评分、静息痛NRS评分明显降低(均P<0.001);与治疗前相比,治疗后3d、7d、14d、3个月、6个月的的爆发痛NRS评分明显降低(均P<0.05),治疗后14d、3个月、6个月时的爆发痛次数以及持续时间都明显降低(均P<0.05);与治疗前比较,患者治疗后7d、14d、3个月、6个月时的触诱发痛的分级都明显降低,差异均有统计学意义(均P<0.05);与治疗前相比,治疗后14d、3个月、6个月的PDI评分明显降低(P<0.05);与治疗前相比,治疗后14d、3个月、6个月的PHQ-9评分和GAD-7评分都明显减少(P<0.05),与术前的药物使用情况相比,治疗后各镇痛药使用人数普遍呈下降趋势;术中及整个随访期间未观察到严重不良事件。结论短时程脊髓电刺激对爆发痛合并触诱发痛的急性期带状疱疹具有较好的临床疗效。 相似文献
2.
目的通过观察丛针浅刺结合电针治疗三叉神经痛(trigeminal neuralgia,TN)的临床疗效,明确其与卡马西平相比是否具有优势。方法将符合纳入标准的44例受试者随机分为治疗组24例和对照组20例。治疗组采用丛针浅刺结合2/100 Hz电针治疗;对照组口服卡马西平片治疗。采用视觉模拟量表(VAS)和简要面部疼痛概况量表(BPI-Facial),观察两组受试者治疗前、治疗2周、治疗4周和治疗结束后2个月(随访期)的疼痛变化。结果与治疗前比较,对照组治疗2周和随访期VAS评分、BPI-Facial评分明显减少(P<0.05),治疗组治疗2周、治疗4周和随访期VAS评分、BPI-Facial评分均明显减少(P<0.05)。治疗组治疗2周、治疗4周和随访期VAS评分及BPI-Facial评分低于对照组(P<0.05)。结论丛针浅刺结合电针治疗TN在疼痛缓解程度、疼痛对面部特定活动及日常生活影响的短时效应、长时效应和后效应上,均优于卡马西平。 相似文献
3.
目的:对Meckel 囊及其周围重要结构进行解剖学研究,并进行模拟穿刺,为提高手术成功率、减少术后
并发症提供解剖学依据。方法:采用甲醛固定的尸头标本,观察和测量Meckel 囊及其毗邻结构相关数据;将卵
圆孔分为内前( Ⅰ)、内后( Ⅱ)、外前( Ⅲ)、外后( Ⅳ)4 个象限,在直视下分别将穿刺针放置于不同象限,模拟
穿刺过程,将球囊置于Meckel 囊中,并记录穿刺结果。结果:Meckel 囊是颅后窝硬脑膜跨过岩尖在颅中窝形成
的一个裂隙样硬脑膜袋,其平均长径(12.56±1.14)mm、宽径(9.17±0.93)mm、高度(4.37±0.85)mm。囊
内包含三叉神经根、三叉神经半月节及其分支,是经皮穿刺球囊压迫术中放置球囊的目标位置,当穿刺针置于卵
圆孔Ⅱ象限时穿刺成功率为75%,高于Ⅰ象限(56%)、Ⅲ象限(25%)和Ⅳ象限(38%),差异具有统计学意义。
结论:成功穿刺Meckel 囊是经皮穿刺球囊压迫术成功的关键,熟悉Meckel 囊及其毗邻重要结构对经皮穿刺球囊
压迫术的操作至关重要,从而提高手术效果,减少术后并发症。 相似文献
4.
目的探讨显微血管减压术(MVD)治疗舌咽神经痛(GPN)的安全性及远期临床疗效。方法回顾性分析39例行显微血管减压术治疗的舌咽神经痛患者的临床资料。所有患者均采用乙状窦后-幕下入路进行显微血管减压手术,术后定期随访。结果所有患者术后早期疗效显著,随访时间为1~9年,平均为4.9年。随访过程中1例患者术后2年出现舌咽神经痛症状复发,1例患者术后1.5年舌咽神经痛症状部分复发。术后出现声音嘶哑及吞咽困难患者4例、脑脊液漏患者1例,均在随访过程中恢复。结论显微血管减压术是治疗舌咽神经痛安全有效且远期效果良好的方法,术前影像学检查对于责任血管的判断有重要意义。 相似文献
5.
6.
原发性三叉神经痛是三叉神经分布区内短暂的发作性剧痛,多发于中老年人,40岁以上患者占70%~80%,发作时表现为面颊上下颌及舌部明显的剧烈电击样、针刺样、刀割样疼痛,持续时间短,突发突止,间歇期完全正常。中医将其归属于"面痛"范畴,多从风热立论,笔者跟随导师临证过程中,发现《医宗金鉴》的芎芷石膏汤治疗风热上犯型原发性三叉神经痛效果显著。 相似文献
7.
《Vaccine》2020,38(18):3501-3507
BackgroundNo national vaccination program against herpes zoster (HZ) is currently in place in Norway. We aimed to quantify the burden of medically attended HZ to assess the need for a vaccination program.MethodsWe linked data from several health registries to identify medically attended HZ cases during 2008–2014 and HZ-associated deaths during1996–2012 in the entire population of Norway. We calculated HZ incidences for primary and hospital care by age, sex, type of health encounter, vaccination status, and co-morbidities among hospital patients. We also estimated HZ-associated mortality and case-fatality.ResultsThe study included 82,064 HZ patients, of whom none were reported as vaccinated against HZ. The crude annual incidence of HZ was 227.1 cases per 100,000 in primary healthcare and 24.8 cases per 100,000 in hospitals. Incidence rates were higher in adults aged ≥50 years (461 per 100,000 in primary care and 57 per 100,000 in hospitals), and women than in men both in primary healthcare (267 vs 188 per 100,000), and hospitals (28 vs 22 per 100,000). Among hospital patients, 47% had complicated zoster and 25% had comorbidities, according to the Charlson comorbidity index. The duration of hospital stay (median 4 days) increased with the severity of comorbidities. The estimated mortality rate was 0.18 per 100,000; and in-hospital case-fatality rate was 1.04%.ConclusionsMedically attended HZ poses a substantial burden in the Norwegian healthcare sector. The majority of the zoster cases occurred among adults aged ≥50 years – the group eligible for zoster vaccination – and increased use of zoster vaccination may be warranted, especially among persons with co-morbidities. 相似文献
8.
《Neurocirugía (Asturias, Spain)》2022,33(5):254-257
The persistent sciatic artery is an uncommon disease, considered an axial congenital vascular malformation due to the lack of involution of the sciatic artery during embryonic development. It may be associated with abnormalities in the development of the iliac, common femoral and superficial femoral arteries. Patients may be asymptomatic, or they could present chronic pain, such as sciatic neuralgia, caused by nerve damage, since it is close to the abnormal persistent vessel, or due to ischemic pain, as a result of a thrombosis or embolism of an aneurysm, which could compromise the viability of the limb. 相似文献
9.
A. Hochsprung S. Escudero-Uribe A.J. Ibáñez-Vera G. Izquierdo-Ayuso 《Neurología (Barcelona, Spain)》2021,36(6):433-439
IntroductionPain is highly prevalent in patients with multiple sclerosis (MS); it is chronic in 50% of cases and is classified as nociceptive, neuropathic, or mixed-type. Pain affects quality of life, sleep, and the activities of daily living. Electrotherapy is an interesting alternative or complementary treatment in the management of pain in MS, with new innovations constantly appearing.Material and methodsThis study evaluates the effectiveness of treatment with monopolar dielectric transmission of pulsed electromagnetic fields (PEMF) for pain associated with MS. We performed a randomised, placebo-controlled clinical trial including 24 patients, who were assessed with the Brief Pain Inventory, the Multiple Sclerosis International Quality of Life questionnaire, the Beck Depression Inventory, and the Modified Fatigue Impact Scale.ResultsStatistically significant improvements were observed in maximum and mean pain scores, as well as in the impact of pain on work, personal relationships, and sleep and rest. Not significant differences were found between the treatment and placebo groups.ConclusionsTreatment with PEMF may be effective in reducing pain in patients with MS, although further research is necessary to confirm its effectiveness over placebo and to differentiate which type of pain may be more susceptible to this treatment. 相似文献
10.
《European annals of otorhinolaryngology, head and neck diseases》2020,137(4):285-289
ObjectivesAnalysis of the long-term efficacy of microvascular decompression surgery in trigeminal neuralgia.Material and methodsA single-center retrospective study included patients undergoing microvascular decompression surgery for trigeminal neuralgia after failure of well-conducted medical or complementary therapy, with visualization of nerve compression syndrome on MRI.ResultsEighty-seven patients were included. Nerve compression was alleviated without interposition of polytetrafluoroethylene in 79.3% of cases. Postoperative efficacy on pain was immediate in 97.7% of cases. There were no postoperative deaths, and the rate of severe complications was low (2.3%). The efficacy of microvascular decompression surgery was total at 2 years in 90.8% of cases and at 10 years in 92.3%, without resumption of medical treatment. The failure rate was 10.3%; 26.3% of these patients had been previously treated by a lesional technique (P: 0.043) and 33.3% by interposition of polytetrafluoroethylene (P: 0.003).ConclusionsWith confirmed clinical and radiological diagnosis, microvascular decompression surgery for trigeminal nerve compression was safe, with total effectiveness in the immediate, short and long terms. It should be considered in first line in case of failure or intolerance of well-conducted medical treatment. 相似文献